Liposomes Co‐Delivering Curcumin and Colistin to Overcome Colistin Resistance in Bacterial Infections

Chengyuan Qin,Ning Tang,Yingying Gan,Huimin Zhao,Yuzhen Li,Guo‐bao Tian,Yi Yan Yang,Peiyan Yuan,Xin Ding
DOI: https://doi.org/10.1002/adhm.202202903
IF: 10
2023-08-02
Advanced Healthcare Materials
Abstract:Antibiotic colistin is the last line of defense against multidrug‐resistant (MDR) Gram‐negative bacterial infections. Emergence of colistin resistance in microbes is a critical challenge. Herein, curcumin was discovered, for the first time, to reverse the resistance phenotype of colistin‐resistant bacteria via a checkerboard assay. For the co‐delivery of curcumin and colistin, negatively charged poly(ethylene glycol)‐functionalized liposomes encapsulating both drugs (Lipo‐cc) were prepared. Killing kinetics and live/dead assays confirmed the antibacterial activity of Lipo‐cc against colistin‐resistant bacteria, which was more potent than that of the free curcumin and colistin combination. Mechanistical studies revealed that Lipo‐cc restored the affinity of colistin for the bacterial membrane and improved the uptake of curcumin, which led to reduced efflux pump activity, achieving a synergistic effect of colistin and curcumin. At the effective antibacterial dose, Lipo‐cc did not exhibit any toxicity. The therapeutic efficacy of Lipo‐cc was further demonstrated in an intestinal bacterial infection model induced with colistin‐resistant Escherichia coli. Lipo‐cc reduced the bacterial burden with over 6‐log reduction and alleviated inflammation caused by infection. Importantly, unlike colistin, Lipo‐cc did not affect the homeostasis of the intestinal flora. Taken together, Lipo‐cc successfully overcame colistin resistance, indicating its potential for the treatment of colistin‐resistant bacterial infections. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?